Coronavirus: China’s first mRNA vaccine ready for final stage trials overseas

• The vaccine ARCoV uses the same revolutionary technique as the Pfizer-BioNTech and Moderna products, and early trials suggest it may prove just as effective
• Work on a production facility in Yunnan province started last year and developers hope to produce over a hundred million doses a year